MORGAN STANLEY PLC/CALL/STRYKER CORP./440/0.1/20.09.24 Stock

Warrant

DE000ME17RH5

Real-time Bid/Ask 04:03:25 2024-05-17 EDT
0.078 EUR / 0.191 EUR +37.76% Intraday chart for MORGAN STANLEY PLC/CALL/STRYKER CORP./440/0.1/20.09.24
Current month-27.41%
1 month-41.32%
Date Price Change
24-05-16 0.098 +4.26%
24-05-15 0.094 -2.08%
24-05-14 0.096 -2.04%
24-05-13 0.098 -7.55%
24-05-10 0.106 +0.95%

Delayed Quote Börse Stuttgart

Last update May 16, 2024 at 11:37 am

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying STRYKER CORPORATION
Issuer Morgan Stanley
WKN ME17RH
ISINDE000ME17RH5
Date issued 2023-09-27
Strike 440 $
Maturity 2024-09-20 (127 Days)
Parity 10 : 1
Emission price 0.18
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.46
Lowest since issue 0.073
Spread 0.112
Spread %58.64%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
334 USD
Average target price
372.4 USD
Spread / Average Target
+11.49%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW